Betaseron
Sponsors
University of Medicine and Dentistry of New Jersey, Teva Branded Pharmaceutical Products R&D, Inc.
Conditions
Multiple SclerosisRelapsing Remitting Multiple Sclerosis
Phase 4
Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI
CompletedNCT00176592
Start: 2003-01-31End: 2007-01-31Updated: 2021-11-16
Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS
TerminatedNCT00202995
Start: 2004-07-31End: 2007-10-31Updated: 2010-10-18